Chronic Hepatitis D
Infectious Diseases
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
GS
Gilead SciencesFOSTER CITY, CA
2 programsBurden of Hepatitis D Virus (HDV) Infection in ItalyN/A1 trial
Burden of Hepatitis D Virus (HDV) Infection in ItalyN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
Mirum PharmaceuticalsBrelovitug
Gilead SciencesBurden of Hepatitis D Virus (HDV) Infection in Italy
Clinical Trials (2)
Total enrollment: 635 patients across 2 trials
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Start: Feb 2026Est. completion: Mar 2029120 patients
Phase 2/3Recruiting
Burden of Hepatitis D Virus (HDV) Infection in Italy
Start: Aug 2022Est. completion: Dec 2024515 patients
N/ACompleted
Related Jobs in Infectious Diseases
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
9h ago
$179K - $237K/yr
Consultor Técnico Vacinas Adulto (Brasília/DF)
GSK
BRA - Distrito Federal - Brasília
22h ago
Production Supervisor/First Line Leader
GSK
USA - North Carolina - Zebulon
22h ago
Community Engagement Account Manager - New Haven
GSK
USA - Connecticut - New Haven
22h ago
Scientist, Protein Purification
GSK
USA - Massachusetts - Cambridge
22h ago
$90K - $150K/yr
Scientist, Protein Biochemistry
GSK
USA - Massachusetts - Cambridge
22h ago
$90K - $150K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 635 patients
2 companies competing in this space